期刊文献+

血友病A发病分子机制的研究现状 被引量:2

Research Status of Molecular Pathogenesis of Hemophilia A
下载PDF
导出
摘要 血友病A的发病机制是凝血因子Ⅷ(FⅧ)基因的各种突变导致FⅧ活性降低,错义突变是轻/中型血友病A发病的主要机制,内含子22的倒位是重型血友病A发病的主要机制。无义突变、剪接位点突点、片段缺失、插入突变占已知突变的其余部分。突变产生的效应包括产生功能缺陷的FⅧ或减少循环中FⅧ的数量。大部分的基因突变已经确定,仍有少量患者检测不到FⅧ基因的突变。该文就血友病A的发病机制予以综述。 Hemophilia A is caused by a wide spectrum of different mutations in the factor Ⅷ gene,leading to deficiencies in coagulation FⅧ activity. Missense mutations are the main mechanism for mild/moderate haemophilia A,while intron 22 inversion is the main mechanism for the pathogenesis of severe hemophilia. Nonsense mutation,splice site mutation,fragment deletion,insertion mutation account for the rest known mutations. The effects that mutations produce contain generating functional defected F Ⅷ or reducing the quantity of the F Ⅷ in circulation. Most of the gene mutations have been identified,while mutation of F Ⅷ gene are still not detected in a small number of patients. Here is to make a review of the pathogenesis of hemophilia A.
出处 《医学综述》 2013年第24期4430-4433,共4页 Medical Recapitulate
关键词 血友病A 凝血因子Ⅷ 分子机制 Hemophilia A Coagulation factor Ⅷ Molecular mechanism
  • 相关文献

参考文献4

二级参考文献47

  • 1陈云弟,王寅文,吴竞生,陈美珏,盛敏,任兆瑞,曾溢滔.因子Ⅷ基因倒位的检测与血友病甲的分子诊断[J].中华血液学杂志,1995,16(9):451-453. 被引量:11
  • 2孙淑娟,张磊,杨仁池,孙洪砚,韩忠朝.血友病骨关节病101例X线表现及临床分析[J].中国综合临床,2006,22(4):326-328. 被引量:24
  • 3郭晔,张磊,竺晓凡,杨仁池.儿童血友病429例临床回顾分析[J].中国实用儿科杂志,2006,21(4):292-295. 被引量:37
  • 4Zhang L,Li H,Zhao H,et al. Retrospective analysis of 1312 patients with haemophilia and related disorders in a single Chinese institute[J]. Haemophilia,2003,9 (6) :696 - 702.
  • 5Wang T, Zhang L, Li H, et al. Assessing health-related quality-of- life in individuals with haemophilia in China [ J ]. Haemophilia, 2004,10(4) :370 -375.
  • 6Yang R, Wang H, Han ZC. Polymorphisms associated with factor Ⅸ gene in Chinese people[ J]. Haemophilia, 1999,5 (6) :453 - 456.
  • 7Fang Y,Wang X, Dai J,et al. A rapid multifluorescent polymerase chain reaction for genetic counseling in Chinese haemophilia A families [ J ]. Haemophilia,2006,12:62 - 67.
  • 8Liang Y, Yan M, Xiao B, et al. Analysis of intron 1 factor Ⅷ gene inversion for direct diagnosis in patients with severe haemophilia A in China[ J ]. Prenat Diagn ,2008,28 ( 2 ) : 160 - 161.
  • 9Shi J, Zhao Y, Wu J, et al. Safety and efficacy of a sucrose-formulated recombinant factor Ⅷ product for the treatment of previously treated patients with haemophilia A in China [ J ]. Haemophilia, 2007,13(4) :351 -356.
  • 10Lu DR, Zhou JM, Zheng B, et al. Stage Ⅰ clinical trial of gene therapy for hemophilia B [ J]. Sci China B, 1993,36 ( 11 ) : 1342 - 1351.

共引文献32

同被引文献19

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部